Abstract
Introduction and hypothesis
The main objective of the study was to evaluate the rates of de novo stress urinary (SUI) and postoperative dyspareunia after both sacrocolpopexy/hysteropexy (SCP) and vaginal mesh surgery.
Methods
A prospective, multicenter, randomized, open-label study with two parallel groups treated by either SCP or Uphold Lite vaginal mesh was carried out. Study participants were ≥ 50 and < 80 years old patients with Pelvic Organ Prolapse Quantification (POP-Q) stage ≥2 who were considered eligible for reconstructive surgery and who were sexually active with no dyspareunia and free from bothersome SUI at presentation. Women were assessed before surgery and at 4–8 weeks and 11–13 months after using validated measures including POP-Q, Pelvic Floor Disability Index (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR), and Patient Global Impression of Improvement (PGI-I). Data were also collected for health economics evaluation.
Results
Of the required sample of 156 women, 42 women (19 SCP and 23 vaginal mesh) were only recruited owing to the discontinuation of vaginal mesh worldwide. The median follow-up was 376 days. The rates of bothersome de novo SUI were similar in the SCP and Uphold vaginal mesh groups (15.79 vs 15.00%, OR 0.95 [95% CI 0.22–4.14]). Among 30 sexually active patients at follow-up, the rates of women reporting de novo dyspareunia “usually or always” were 6.7% after SCP vs 13.3% after vaginal mesh (p = 1). Health economics evaluation showed a cost saving of 280€ in favor of the Uphold vaginal mesh technique, but no significant difference in the total cost (2,934.97€ for SCP vs 3,053.26€ for Uphold vaginal mesh).
Conclusions
Bothersome de novo SUI and de novo dyspareunia occurred in approximately 15% and 23% of our study cohorts, with no significant difference between sacrocolpopexy/hysteropexy and anterior/apical vaginal mesh surgery. However, these results should be interpreted with caution owing to the small sample size.
Similar content being viewed by others
References
Fritel X, Varnoux N, Zins M, et al. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol. 2009;113:609–16. https://doi.org/10.1097/AOG.0b013e3181985312.
Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501–6. https://doi.org/10.1016/S0029-7844(97)00058-6.
Lucot JP, Cosson M, Bader G, et al. Safety of vaginal mesh surgery versus laparoscopic mesh sacropexy for cystocele repair: results of the prosthetic pelvic floor repair randomized controlled trial. Eur Urol. 2018;74:167–76. https://doi.org/10.1016/j.eururo.2018.01.044.
Maher C, Feiner B, Baessler K, et al. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. Cochrane Database Syst Rev. 2016;2(2):CD012079.
Vu MK, Letko J, Jirschele K, et al. Minimal mesh repair for apical and anterior prolapse: initial anatomical and subjective outcomes. Int Urogynecol J Pelvic Floor Dysfunct. 2012;23:1753–61. https://doi.org/10.1007/s00192-012-1780-5.
Letouzey V, Ulrich D, Balenbois E, et al. Utero-vaginal suspension using bilateral vaginal anterior sacrospinous fixation with mesh: intermediate results of a cohort study. Int Urogynecol J. 2015;26:1803–7. https://doi.org/10.1007/s00192-015-2748-z.
Altman D, Mikkola TS, Bek KM, et al. Pelvic organ prolapse repair using the Uphold™ vaginal support system: a 1-year multicenter study. Int Urogynecol J. 2016;27:1337–45. https://doi.org/10.1007/s00192-016-2973-0.
Lucot JP, Cosson M, Verdun S, et al. Long-term outcomes of primary cystocele repair by transvaginal mesh surgery versus laparoscopic mesh sacropexy: extended follow up of the PROSPERE multicentre randomised trial. BJOG. 2022;129(1):127–37. https://doi.org/10.1111/1471-0528.16847.
Baessler K, Christmann-Schmid C, Maher C, et al. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst Rev. 2018;8(8):CD013108.
Fatton B, de Tayrac R, Letouzey V, Huberlant S. Pelvic organ prolapse and sexual function. Nat Rev Urol. 2020;17:373–90.
Fatton B, Hermieu J-F, Lucot J-P, et al. French validation of the pelvic organ prolapse/incontinence sexual questionnaire-IUGA revised (PISQ-IR). Int Urogynecol J. 2021;32(12):3183–98. https://doi.org/10.1007/s00192-020-04625-6.
Leruth J, Fillet M, Waltregny D. Incidence and risk factors of postoperative stress urinary incontinence following laparoscopic sacrocolpopexy in patients with negative preoperative prolapse reduction stress testing. Int Urogynecol J Pelvic Floor Dysfunct. 2013;24:485–91. https://doi.org/10.1007/s00192-012-1888-7.
Wagner L, Boileau L, Delmas V, et al. Surgical treatment of prolapse using coelioscopic promontofixation: techniques and results. Prog Urol. 2009;19:994–1005.
LeClaire EL, Mukati MS, Juarez D, et al. Is de novo stress incontinence after sacrocolpopexy related to anatomical changes and surgical approach? Int Urogynecol J. 2014;25:1201–6. https://doi.org/10.1007/s00192-014-2366-1.
Salerno J, de Tayrac R, Droupy S, et al. Impact de la promonto-fixation cœlioscopique, avec ou sans bandelette sous-urétrale, sur les symptômes du bas appareil urinaire. Prog Urol. 2016;26:401–8. https://doi.org/10.1016/j.purol.2016.03.003.
Bousserghine Y, Droupy S, Wagner L, et al. Incontinence urinaire d’effort de novo après promontofixation. Prog Urol. 2011;21:631–5. https://doi.org/10.1016/j.purol.2011.04.004.
El Hamamsy D, Fayyad AM. New onset stress urinary incontinence following laparoscopic sacrocolpopexy and its relation to anatomical outcomes. Int Urogynecol J. 2015;26:1041–5. https://doi.org/10.1007/s00192-015-2641-9.
Holt E. US FDA rules manufacturers to stop selling mesh devices. Lancet. 2019;393:1686. https://doi.org/10.1016/S0140-6736(19)30938-9.
Department of Error. Lancet. 2019;393:2124. https://doi.org/10.1016/S0140-6736(19)31093-1
Maher CF, Feiner B, Decuyper EM, et al. Laparoscopic sacral colpopexy versus total vaginal mesh for vaginal vault prolapse: a randomized trial. Am J Obstet Gynecol. 2011;204:360.e1–7. https://doi.org/10.1016/j.ajog.2010.11.016.
Bataller E, Ros C, Anglès S, et al. Anatomical outcomes 1 year after pelvic organ prolapse surgery in patients with and without a uterus at a high risk of recurrence: a randomised controlled trial comparing laparoscopic sacrocolpopexy/cervicopexy and anterior vaginal mesh. Int Urogynecol J. 2019;30:545–55. https://doi.org/10.1007/s00192-018-3702-7.
Gutman RE, Rardin CR, Sokol ER, et al. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol. 2017;216:38.e1–11.
To V, Hengrasmee P, Lam A, et al. Evidence to justify retention of transvaginal mesh: comparison between laparoscopic sacral colpopexy and transvaginal Elevate™ mesh. Int Urogynecol J. 2017;28:1825–32. https://doi.org/10.1007/s00192-017-3379-3.
Wei D, Wang P, Niu X, Zhao X. Comparison between laparoscopic uterus/sacrocolpopexy and total pelvic floor reconstruction with vaginal mesh for the treatment of pelvic organ prolapse. J Obstet Gynaecol Res. 2019;45:915–22. https://doi.org/10.1111/jog.13908.
Ehlert MJ, Gupta P, Park J, Sirls LT. Detailed cost analysis of robotic sacrocolpopexy compared to transvaginal mesh repair. Urology. 2016;97:86–91. https://doi.org/10.1016/j.urology.2016.05.072.
Myoga M, Sho T, Aoki H, et al. Cost analysis of four types of surgeries for pelvic organ prolapse in a Japanese population. J Obstet Gynaecol Res. 2021;47:1567–71. https://doi.org/10.1111/jog.14683.
Acknowledgements
The authors would like to thank Ms. Pascale Fabbro-Peray for her methodological advice and Ms. Stéphanie Salles for her input in data management. The authors would also like to thank Superviseme Ltd medical writing services (http://www.superviseme.eu) for help with the medical writing and editing of the manuscript.
Funding
Nimes University Hospital, France, and Boston Scientific.
Author information
Authors and Affiliations
Contributions
R. de Tayrac: project development, data collection, data analysis, manuscript editing; G. Lamblin: data collection; M. Cosson: project development, data collection; L. Panel: data collection; C. Compan: data collection; L. Wagner: data collection; Z. Zemmache: data management, data analysis; S. Bouvet: data analysis; B. Fatton: project development.
Corresponding author
Ethics declarations
Conflicts of interest
R. de Tayrac, M. Cosson, and B. Fatton are consultants for Boston Scientific. The remaining authors claim no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Tayrac, R., Cosson, M., Panel, L. et al. Urinary and sexual impact of pelvic reconstructive surgery for genital prolapse by surgical route. A randomized controlled trial. Int Urogynecol J 33, 2021–2030 (2022). https://doi.org/10.1007/s00192-021-05071-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-021-05071-8